CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
- 1 January 2000
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 102 (1), 98-106
- https://doi.org/10.1016/s0165-5728(99)00166-6
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- CCR5 promoter polymorphism and HIV-1 disease progressionThe Lancet, 1998
- Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesionsJournal of Neuroimmunology, 1998
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- A YAC Contig of the Human CC Chemokine Genes Clustered on Chromosome 17q11.2Genomics, 1996
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantationTissue Antigens, 1992
- In Vivo Activated T Lymphocytes in the Peripheral Blood and Cerebrospinal Fluid of Patients with Multiple SclerosisNew England Journal of Medicine, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983